placeholder image
Y. Huang All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial. 
    JAMA surgery. 2021
  • Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 
    Lancet Oncology. 2018
  • Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. 
    New England Journal of Medicine. 2017
  • Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial. 
    Lancet Oncology. 2016
  • Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. 
    American Journal of Clinical Nutrition. 2011
    • Contact
    full name
  • Y. Huang
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration